Project Grant HT94252310568
Award Date 7/1/23
Completion Date 6/30/25
Dollars Obligated $250K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Newark, NJ 07102, USA
Similar Awards
- The Defense Health Agency awarded Rutgers, The State University a $471,000 project grant under the Military Medical Research and Development program (CFDA 12.420) to develop new therapeutic strategies for chemo brain in ovarian cancer survivors. The grant period runs from July 1, 2023 through June 30, 2027 in New Brunswick, New Jersey. Through its Research Financial Services division, Rutgers will leverage its expertise in bioengineering and disease research to investigate medical solutions...
- Rutgers The State University Of New Jersey, doing business as Rbhs-School Of Nursing, was awarded a $785,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund development of new therapeutic strategies for chemo brain in ovarian cancer survivors from July 1, 2023 through June 30, 2027. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform...
- The Department of the Army Medical Command awarded Rutgers, The State University of New Jersey a $751,587 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research targeting adenosine kinase for the prevention of post-traumatic epilepsy from September 30, 2022 to September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $649,000.00 to Rutgers, The State University of New Jersey to characterize the oncogenic transcriptional activation during the malignant transformation of NF1 nerve sheath tumors. The 3-year award, effective from August 1, 2025 through July 31, 2028, will support specialized biomedical research aimed at transforming healthcare for military service members,...
- The Defense Health Agency awarded Rutgers, The State University of New Jersey a $942,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support targeted chemotherapeutic and immunotherapeutic research for drug-resistant ovarian cancer. The three-year award beginning April 1, 2023 will fund Rutgers Biomedical and Health Sciences' investigation into medical solutions for this treatment-resistant form of ovarian cancer through innovative research...
- The Defense Health Agency awarded a $319,240 Project Grant to The Johns Hopkins University to conduct research on characterizing microRNAs (miRNAs) involved in regulating human oligodendrocyte maturation and myelin formation. This research falls under the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical investigations to transform healthcare for military service members, veterans, and the broader public. The award period runs from September 1,...
- This federal Project Grant award of $785,000.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports mechanism-centric predictive modeling research for prostate cancer at Rutgers, The State University of New Jersey. The research aims to develop innovative approaches for improving diagnosis, treatment, and outcomes for military personnel and the public impacted by prostate cancer. Over the performance period from July 1, 2024...
- The federal Project Grant award of $658,903.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Rutgers, The State University in New Brunswick, NJ. The award is for the "GENETIC IMMUNODETECTION AND TREATMENT OF VCA REJECTION" project, with a performance period from September 1, 2025 to August 31, 2028. The grant supports advanced biomedical research aimed at transforming healthcare for military service members,...
- This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $768,420.00 in funding to Rutgers, The State University of New Jersey to conduct research on "Rewiring Very Long Chain Fatty Acid Metabolism in Pancreatic Tumor-Associated Macrophages to Overcome KRAS-Targeted Therapy Resistance." The project aims to investigate metabolic pathways in pancreatic cancer that contribute to treatment resistance, with the goal...
- The federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,000,000.00 to Duke University to develop a novel umbilical cord blood-derived cell therapy to suppress neuroinflammation and promote remyelination. The award period runs from September 1, 2025 to August 31, 2028. This research aims to transform healthcare for military service members, veterans, and the broader public by advancing biomedical innovations in...